Begin commercialization of LNZ100
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 3 Apr 2024
- Due
- 31 Dec 2025
- Delivered
- August 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“preparations for commercialization in second half of 2025 upon FDA approval”
What we found
Evidence strength A What the grades mean
LENZ Therapeutics commercially launched VIZZ (formerly LNZ100) in August 2025, following FDA approval in July 2025, successfully meeting the commitment to begin commercialization in the second half of 2025.
-
A LENZ Therapeutics, Inc. 10-K filed 2026-03-24
“The Company commercially launched VIZZ in the U.S. in August 2025, with direct-to-eye care professional sales and marketing activities initiated immediately upon approval.” ✓ confirmed on the page
Market reaction: the shares moved -17.2% against the S&P 500 over the three sessions around the disclosure (23 Mar 2026 to 26 Mar 2026). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Begin
- Deliverable
- commercialization of LNZ100
- In the company’s control
- Medium
- Specificity
- Medium
- Conditional
- Yes: upon FDA approval
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you LENZ Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-LENZ-003362 · Corrections policy